Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B

tolerogenic dendritic cells loaded with myelin peptides - Clinical Foundation of Barcelona

http://clinicaltrials.gov/ct2/show/NCT02283671

Feb 16, 2019